Absence of dysferlin alters myogenin expression and delays human muscle differentiation "in vitro"

Noemí De Luna, Eduard Gallardo, Mario Soriano, Raúl Dominguez-Perles, Carolina De La Torre, Ricardo Rojas-García, Jose M. García-Verdugo, Isabel Illa

Research output: Contribution to journalArticleResearchpeer-review

89 Citations (Scopus)


Mutations in dysferlin cause a type of muscular dystrophy known as dysferlinopathy. Dysferlin may be involved in muscle repair and differentiation. We compared normal human skeletal muscle cultures expressing dysferlin with muscle cultures from dysferlinopathy patients. We quantified the fusion index of myoblasts as a measure of muscle development and conducted optic and electronic microscopy, immunofluorescence, Western blot, flow cytometry, and real-time PCR at different developmental stages. Short interference RNA was used to corroborate the results obtained in dysferlin-deficient cultures. A luciferase reporter assay was performed to study myogenin activity in dysferlin-deficient cultures. Myoblasts fusion was consistently delayed as compared with controls whereas the proliferation rate did not change. Electron microscopy showed that control cultured cells at 10 days were fusiform, whereas dysferlin-deficient cells were star-shaped and large. After 15 days the normal multinucleated appearance and structured myofibrils were not present in dysferlin-deficient cells. Strikingly, myogenin was not detected in myotubes from dysferlin-deficient cultures using Western blot, and mRNA analysis showed low levels (p < 0.05) compared with controls. Flow cytometry and immunofluorescence also showed reduced levels of myogenin in dysferlin-deficient cultures. When the dysferlin gene was knocked down (∼80%), myogenin mRNA leveled down to ∼70%. MyoD and desmin mRNA levels in controls and dysferlin-deficient cultures were similar. The reporter luciferase assay demonstrated a low myogenin activity in dysferlin-deficient cultures. These results point to a functional link between dysferlin and myogenin, and both proteins may share a new signaling pathway involved in differentiation of skeletal muscle in vitro. © 2006 by The American Society for Biochemistry and Molecular Biology, Inc.
Original languageEnglish
Pages (from-to)17092-17098
JournalJournal of Biological Chemistry
Issue number25
Publication statusPublished - 23 Jun 2006


Dive into the research topics of 'Absence of dysferlin alters myogenin expression and delays human muscle differentiation "in vitro"'. Together they form a unique fingerprint.

Cite this